DPP-4 inhibitors for Type 2 Diabetes. Who, when, and why?
Upon completion of this program, you will be able to confidently identify patient groups likely to benefit from DPP4is, and have the knowledge to appropriately prescribe DPP4is.
Sign up for free and continue reading
Med CPD offers the widest range of courses and content, all accessible in one place. Click on the Sign up button and start looking after the health of your career.
MDBriefCase Group Inc.
Speakers
Anita Sharma
Tom Dover
Duration
1 H
Accredited
-
RACGP - Royal Australian College of General Practitioners
Other courses
Become a Med CPD member for free, and the rest comes easy.
Quality Education From









